Abstract
A 15-year-old female with pre-pre B ALL in third relapse was treated with administration of eight blood bank leukocyte concentrates per day for 5 days. The total number of mononuclear cells per kilogram of weight was 4.89 × 108. On the fifth day of infusions the patient was in complete remission (CR), asymptomatic and with a normal CBC. No secondary effects were found. The patient remained in CR without treatment for 10 weeks before relapsing again. The possibility of reaching a short-lived, clinically relevant response, using blood bank leukocyte infusions, is a promising new approach for the treatment of leukemia.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Borbolla, J., López, M., Alvarado, M. et al. Blood bank leukocyte infusions as remission induction therapy in a case of acute lymphoblastic leukemia. Bone Marrow Transplant 20, 707–708 (1997). https://doi.org/10.1038/sj.bmt.1700953
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/sj.bmt.1700953